PDGFC and cancer: Knockdown of FTO suppressed cancer growth in a mouse xenograft model by increasing the m6A level of platelet‐derived growth factor C (PDGFC) mRNA, promoting PDGFC mRNA degradation by binding to YTHDF2, decreasing PDGFC secretion, and inhibiting the AKT signaling pathway [62].